Pricing Log in Create free account

Enlivex Ltd. (ENLV) vs Propanc Biopharma Inc (PPCB)

Enlivex Ltd. and Propanc Biopharma Inc are both Biotechnology companies. Enlivex Ltd. is the larger, with a market value of $2.0M against $1.7M — 1.2× the size. Propanc Biopharma Inc has negative trailing earnings, so its P/E is not meaningful; Enlivex Ltd. trades at 0.0×. Across the 11 metrics below, Enlivex Ltd. leads on 9 and Propanc Biopharma Inc on 2.

Valuation

Metric ENLV PPCB Biotechnology median
P/E 0.00 n/m 10.60
P/S n/m n/m 9.40
P/B 0.00 0.02 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 240.80 0.00 0.66
EV/Sales n/m n/m 9.02
Earnings yield 657,517.54% (6,564.98%) (32.88%)
Free cash flow yield (798.45%) (2,826.85%) (23.13%)

Profitability

Metric ENLV PPCB Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 159.77% (169.85%) (51.96%)
Return on assets 127.16% (122.15%) (46.06%)
Return on invested capital (5.85%) (125.86%) 0.00%

Growth

Metric ENLV PPCB Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 3,580.76% 95.48% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENLV PPCB Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 119.39 2.55 4.97
Net debt to EBITDA 118.29 0.02 1.01

Dividend

Metric ENLV PPCB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ENLV PPCB Biotechnology median
Market cap 1.95m 1.69m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack